SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (974)6/8/1997 5:24:00 PM
From: I. Luttichuys   of 1762
 
Yes, I am taking your angle on this. I believe we will move through to approval smoothly on C2B8 and, as you point out, we have all waited a long time for this day that IDEC would become a drug company with an approved product on the market.
As I have pointed out on the thread, I see nothing but clear skies ahead for this product and one becomes increasingly impressed over the positive press we are receiving so far.
If we are to hear from Mr. Hecht, I can't believe that it would be long. The timing is starting to long good. It would go a long way to soothe my uncertainty about CE9.1 as well as I know Mr. Hecht to be quite on top of his picks.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News